Tirzepatide
Targets both GLP-1 and GIP receptors
Tirzepatide activates both GLP-1 and GIP receptors, which can produce stronger appetite and metabolic effects than single-agonist therapy. Dosing is titrated slowly under provider supervision.
- Dual GLP-1 and GIP action
- Once-weekly injection
- Structured titration schedule
- Ongoing provider follow-up
Tirzepatide questions
Care that starts in minutes, not months.
- 01
Choose your treatment
Pick the program that fits your goals.
- 02
Checkout
Flat monthly pricing. No insurance needed.
- 03
Complete your intake
Answer a short health questionnaire online.
- 04
Provider review
A licensed U.S. provider reviews your history and confirms your plan.
- 05
Medication delivered
Your prescription ships discreetly, with follow-ups included.
Intake completed and submitted for provider review.
A licensed provider reviews your history and confirms your plan.
Medication arrives with dosing guidance from your provider.
Check-in, dose adjustment, and labs when clinically useful.
Timelines are typical and vary by state requirements and clinical review.
Prescription products require an online consultation with a healthcare professional who will determine if a prescription is appropriate. You will be notified through email, text/SMS, or your online Hypergevity portal if approved. Compounded medications are not FDA-approved and have not been evaluated by the FDA for safety or effectiveness. If receiving treatment for other conditions, your provider may prescribe FDA-approved generic or brand prescription drugs. If you are unsure, always ask your provider which medication they are prescribing.
Start your visit today.
Complete a short online intake and a licensed provider will review your plan.